$CUPR +50% PREMARKET 🚀 🔹 Huge early move as traders pile into this micro-cap biotech runner 📈 🔹 Cuprina develops biomedical products across chronic wounds,

$CUPR +50% PREMARKET 🚀 🔹 Huge early move as traders pile into this micro-cap biotech runner 📈 🔹 Cuprina develops biomedical products across chronic wounds, infertility, medical waste recycling, and cosmeceuticals 🧬 🔹 Major recent catalyst: MEDIFLY Maggots received U.S. FDA 510(k) clearance for…